Increased MCP-1 has been shown to contribute to a variety of disease states, including Alzheimer’s disease,[43] atherosclerosis[44, 45], increased risk for AD following traumatic brain injury[46], insulin resistance[47], and neuronal death following ischemia[48]. Here, CCL2 is linked to Insulin resistance.